Aminosalicylate: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 34: | Line 34: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 17:09, 18 March 2025
Aminosalicylate is a type of drug used in the treatment of tuberculosis. It is also known as para-aminosalicylic acid (PAS) and is often used in combination with other antibiotics to treat tuberculosis. Aminosalicylate is also used in the treatment of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.
Mechanism of Action[edit]
Aminosalicylate works by inhibiting the synthesis of folic acid in bacteria, which is necessary for the bacteria to survive and multiply. It is bacteriostatic, meaning it stops the growth of bacteria rather than killing them directly.
Side Effects[edit]
Like all drugs, aminosalicylate can cause side effects. These can include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, it can cause serious side effects such as liver damage and hypersensitivity reactions.
Drug Interactions[edit]
Aminosalicylate can interact with other drugs, including rifampin, isoniazid, and pyrazinamide. It can also interact with vitamin B12, reducing its absorption and potentially leading to vitamin B12 deficiency.
Dosage and Administration[edit]
The dosage of aminosalicylate depends on the patient's weight and the severity of their condition. It is usually taken orally, but can also be administered intravenously in severe cases.
